Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models. Syapse Precision Medicine Platform is a comprehensive software suite used by leading health systems to support the clinical implementation of precision medicine in oncology and other service lines. This category-defining platform enables clinical and genomic data integration, decision support, care coordination, and quality improvement at point of care.

Palo Alto, US
Size (employees)
156 (est)+9%
Syapse was founded in 2008 and is headquartered in Palo Alto, US
Report incorrect company information

Syapse Office Locations

Syapse has offices in San Francisco, Philadelphia and Palo Alto
Palo Alto, US (HQ)
230 101 University Ave
Show all (3)
Report incorrect company information

Syapse Financials and Metrics

Summary Metrics

Syapse's latest funding round in November 2017 was reported to be $30 m. In total, Syapse has raised $69.6 m
Show all financial metrics
Report incorrect company information

Syapse News and Updates

Predictive Genetic Testing & Consumer/Wellness Genomics Market Is Expected To Play a Seminal Role in the Ultimate Discovery of Personalized Therapies and Medicines

The offerings of predictive genetic testing and consumer/wellness genomics market is expected to play a seminal role in the ultimate discovery of personalized therapies and medicines. World over, several direct-to-consumer (DTC) genetic testing and healthcare providers offer genetic testing products…

VC-backed Syapse hires oncology VP

San Francisco-based Syapse, a provider of precision medicine solutions, has named Dr. Aradhana Ghosh as vice president of oncology. Ghosh is a former medical oncologist at IBM Watson Health. Syapse's backers include Social Capital, Safeguard Scientifics, Ascension Ventures, GE Ventures, Intermountai…
Report incorrect company information